Candida auris: lessons learnt from the first detected case in Aotearoa New Zealand
N Z Med J
.
2023 Aug 4;136(1580):78-80.
doi: 10.26635/6965.6222.
Authors
Shivani Fox-Lewis
1
,
Leanne Buckwell
2
,
Wendy McKinney
3
,
Ruishan Tang
4
,
Graham Upton
5
,
Bindu Francis
5
,
Sally Roberts
6
Affiliations
1
Clinical Microbiology registrar, Microbiology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
2
Medical Laboratory Scientist Mycology, Microbiology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
3
Section Leader Mycology, Microbiology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
4
Haematology registrar, Auckland City Hospital, Auckland, New Zealand.
5
Nurse Specialist Infection Prevention and Control, Auckland City Hospital, Auckland, New Zealand.
6
Clinical Microbiologist, Head of Department Microbiology, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
PMID:
37536315
DOI:
10.26635/6965.6222
No abstract available
Publication types
Case Reports
MeSH terms
Antifungal Agents* / therapeutic use
Candida auris*
Humans
Microbial Sensitivity Tests
New Zealand
Substances
Antifungal Agents